David Pendarvis Resmed Inc (RSMDF) insider trading activity

David Pendarvis is Chief Administrative Officer of RESMED INC. Currently has a direct ownership of 89,729 shares of RSMDF, which is worth approximately $0. The most recent transaction as insider was on Jun 05, 2023, when has been sold 1,500 shares (ResMed Common Stock) at a price of $219.79 per share, resulting in proceeds of $329,685. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 89.7K

0% 3M change

0% 12M change

Total Value Held $0

DAVID PENDARVIS Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 05 2023	SELL Open market or private sale	$329,685 $219.79 p/Share	1,500 Reduced 1.64%	89,729 ResMed Common Stock
May 03 2023	SELL Open market or private sale	$356,460 $237.64 p/Share	1,500 Reduced 1.62%	91,172 ResMed Common Stock
Apr 03 2023	SELL Open market or private sale	$327,345 $218.23 p/Share	1,500 Reduced 1.59%	92,672 ResMed Common Stock
Mar 03 2023	SELL Open market or private sale	$325,035 $216.69 p/Share	1,500 Reduced 1.57%	94,172 ResMed Common Stock
Feb 03 2023	SELL Open market or private sale	$336,750 $224.5 p/Share	1,500 Reduced 1.54%	95,672 ResMed Common Stock
Jan 03 2023	SELL Open market or private sale	$315,105 $210.07 p/Share	1,500 Reduced 1.52%	97,172 ResMed Common Stock
Dec 05 2022	SELL Open market or private sale	$344,715 $229.81 p/Share	1,500 Reduced 1.5%	98,672 ResMed Common Stock
Nov 28 2022	SELL Bona fide gift	-	7,300 Reduced 6.79%	100,172 ResMed Common Stock
Nov 25 2022	BUY Exercise of conversion of derivative security	$99,950 $146.34 p/Share	683 Added 0.63%	107,472 ResMed Common Stock
Nov 23 2022	SELL Payment of exercise price or tax liability	$1,550,828 $224.4 p/Share	6,911 Reduced 6.08%	106,789 ResMed Common Stock
Nov 23 2022	BUY Grant, award, or other acquisition	-	12,389 Added 9.83%	113,700 ResMed Common Stock
Nov 11 2022	SELL Payment of exercise price or tax liability	$240,041 $225.18 p/Share	1,066 Reduced 1.04%	101,311 ResMed Common Stock
Nov 03 2022	SELL Open market or private sale	$332,530 $215.23 p/Share	1,545 Reduced 1.49%	102,334 ResMed Common Stock
Oct 03 2022	SELL Open market or private sale	$340,194 $220.19 p/Share	1,545 Reduced 1.47%	103,879 ResMed Common Stock
Sep 06 2022	SELL Open market or private sale	$335,141 $216.92 p/Share	1,545 Reduced 1.44%	105,424 ResMed Common Stock
Aug 18 2022	BUY Grant, award, or other acquisition	-	1,683 Added 1.55%	106,969 ResMed Common Stock
Aug 03 2022	SELL Open market or private sale	$371,912 $240.72 p/Share	1,545 Reduced 1.45%	105,286 ResMed Common Stock
Jul 05 2022	SELL Open market or private sale	$328,050 $212.33 p/Share	1,545 Reduced 1.43%	106,831 ResMed Common Stock
Jun 03 2022	SELL Open market or private sale	$323,585 $209.44 p/Share	1,545 Reduced 1.41%	108,376 ResMed Common Stock
May 03 2022	SELL Open market or private sale	$309,000 $200.0 p/Share	1,545 Reduced 1.39%	109,858 ResMed Common Stock
Apr 04 2022	SELL Open market or private sale	$380,750 $246.6 p/Share	1,544 Reduced 1.37%	111,403 ResMed Common Stock
Mar 03 2022	SELL Open market or private sale	$386,957 $250.62 p/Share	1,544 Reduced 1.35%	112,947 ResMed Common Stock
Feb 03 2022	SELL Open market or private sale	$359,551 $232.87 p/Share	1,544 Reduced 1.33%	114,491 ResMed Common Stock
Jan 03 2022	SELL Open market or private sale	$399,155 $258.52 p/Share	1,544 Reduced 1.31%	116,035 ResMed Common Stock
Dec 03 2021	SELL Open market or private sale	$398,244 $257.93 p/Share	1,544 Reduced 1.3%	117,579 ResMed Common Stock

Also insider at

WDFC

WD 40 CO Basic Materials

David Pendarvis

Chief Administrative Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RSMDF shares.

Notify only if

Value

Insider Trading

Get notified when an Resmed Inc insider buys or sells RSMDF shares.

Notify only if

Operation

Value

Type

News

Receive news related to RESMED INC

Track Activities on RSMDF

Account